| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
334,813
|
354,589
|
372,882
|
371,268
| | Cost of Revenue | 246,386 | 263,852 | 284,288 | 290,086 | | |
Gross Profit
|
88,427
|
90,737
|
88,594
|
81,182
| |
|
Operating Expenses |
|
Research Development | 32,133 | 31,484 | 32,913 | 21,930 |
|
Selling General and Administrative | 25,187 | 27,934 | 24,368 | 33,159 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
31,107
|
31,319
|
31,313
|
26,093
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 566 | (10,206) | 61 | 445 |
|
Earnings Before Interest And Taxes | 31,673 | 21,113 | 31,374 | 26,538 |
|
Interest Expense | 1,110 | 2,711 | 2,517 | 2,970 |
|
Income Before Tax | 30,563 | 18,402 | 28,857 | 23,568 |
|
Income Tax Expense | 10,961 | 4,455 | 9,404 | 8,955 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 19,602 | 3,686 | 19,453 | 14,613 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
19,602
|
13,947
|
19,453
|
14,613
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
19,602
|
13,947
|
19,453
|
14,613
|
|
0.03(0.16%) 11:38AM EDT - Nasdaq Real Time Price